Many individuals seeking asylum in the United States show increased stress and pain symptoms that are associated with indications of cardiovascular disease, according to Weill Cornell Medicine researchers.
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.
A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic pelvic pain and improve the quality of life for women with pelvic venous disease.
The White House has recognized six Cornell faculty members, three from the Ithaca campus and three from Weill Cornell Medicine, with 2025 Presidential Early Career Awards for Scientists and Engineers. The awards were announced Jan. 14.
In recognition of her work uniting students, designers and educators across generations to reimagine a play space that fosters creativity, inclusion and active play, Prof. Loebach has received this year’s George D. Levy Engaged Teaching and Research Award.
A total of 450 expected graduates in the Class of 2025 received their degrees from Weill Cornell Medicine during the institution’s annual Commencement ceremony, held May 15 at Carnegie Hall.
A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, according to a preclinical study by Weill Cornell Medicine investigators.
A Cornell-led collaboration uncovered the equipment that enables bacteria to survive exposure to antibiotics: a shuttling mechanism that helps a complex of proteins pump out a wide spectrum of antibiotics from the cell.